Muscle disease in progressive systemic sclerosis: diagnostic and therapeutic considerations.
about
Measurement of clinical change in progressive systemic sclerosis: a 1 year double-blind placebo-controlled trial of N-acetylcysteine.Scleroderma-polymyositis overlap syndrome versus idiopathic polymyositis and systemic sclerosis: a descriptive study on clinical features and myopathologyNeuromuscular complications of connective tissue diseases.Course of dermal ulcers and musculoskeletal involvement in systemic sclerosis patients in the scleroderma lung study.An overview of polymyositis and dermatomyositis.Hypoventilatory respiratory failure in generalised scleroderma.Up regulated expression of tumour necrosis factor {alpha} converting enzyme in peripheral monocytes of patients with early systemic sclerosisLower limb muscle strength is associated with functional performance and quality of life in patients with systemic sclerosis.Aldolase predicts subsequent myopathy occurrence in systemic sclerosisAn explanatory model of functional exercise capacity in patients with systemic sclerosis: considerations for rehabilitation programs.Corticosteroid induced remission of oesophageal involvement in mixed connective tissue disease.Systemic sclerosis-associated myopathy.Histopathological findings in systemic sclerosis-related myopathy: fibrosis and microangiopathy with lack of cellular inflammation.Seizures in systemic sclerosis.Fibrosing myopathy in systemic sclerosis associates with higher mortality.Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial.Polymyositis, a very uncommon isolated disease: clinical and histological re-evaluation after long-term follow-up.Myopathies related to systemic sclerosis: a case-control study of associated clinical and immunological features.Myopathy is a poor prognostic feature in systemic sclerosis: results from the Canadian Scleroderma Research Group (CSRG) cohort.Muscle involvement in systemic sclerosis: points to consider in clinical trials.Clinical characteristics of scleroderma overlap syndromes: comparisons with pure scleroderma.Aerobic and resistance exercise in systemic sclerosis: State of the art.Scleroderma Lung Disease
P2860
Q33551996-4F408511-8F6E-44B4-A49F-24328B0B49D5Q33765558-863A6ABC-2C97-48BE-8F6D-0991B8AEE7A0Q34141653-1CD2AF00-3AC6-4C64-8DE4-E3BBB4B33EE8Q34367492-51DBEAEA-2148-4084-8D10-AE2F3A94DEAAQ34667765-D81A1696-CB3A-4E1A-92F5-FC441C8DAC2CQ34990990-07C64ED1-B5CE-4660-837C-A284A6A2EAA0Q35555901-EA272E39-1308-47AF-AEF7-40B160EC99B8Q35785365-18F3A253-2748-4253-A661-84F8E9FAE2F3Q36246152-57148E2C-EE4E-4D7B-9C74-B996306A25C9Q36690377-4E12D5DC-CB72-4DF2-80CF-F9E8002B336BQ36717229-D901DACE-A03A-443F-89F3-0F93C04437C9Q36953475-85908332-5B3C-460F-B530-E20459CD78D7Q37582535-27747AF6-B5B6-42A7-A77C-4E4F257A521CQ38070319-C763720F-2A12-4D06-935B-F7F3A3A07404Q38763676-64EE0DCD-DFC5-45A2-88A6-F5CAB8719AE7Q40700292-CC548ABD-56F8-41CD-B433-4C635845138FQ41577325-493BC4FD-9569-4699-9CCA-C51FA8B04732Q42931182-166AE6E5-ADA7-401B-8472-73CA863716ECQ44628402-90742922-D40D-435A-9EA5-13CEF365E682Q46256178-03CCBAD3-180B-4B14-AAA8-2CDE0FF9B411Q47811839-DBE012F7-129D-4CED-ADE1-2608CE58190AQ53744989-377815B5-424C-4F4C-8E3B-E55839D679B9Q56977976-4DFA6052-B17F-499B-AEFB-CD6859D93C38
P2860
Muscle disease in progressive systemic sclerosis: diagnostic and therapeutic considerations.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年学术文章
@wuu
1978年学术文章
@zh
1978年学术文章
@zh-cn
1978年学术文章
@zh-hans
1978年学术文章
@zh-my
1978年学术文章
@zh-sg
1978年學術文章
@yue
1978年學術文章
@zh-hant
name
Muscle disease in progressive ...... nd therapeutic considerations.
@en
Muscle disease in progressive ...... nd therapeutic considerations.
@nl
type
label
Muscle disease in progressive ...... nd therapeutic considerations.
@en
Muscle disease in progressive ...... nd therapeutic considerations.
@nl
prefLabel
Muscle disease in progressive ...... nd therapeutic considerations.
@en
Muscle disease in progressive ...... nd therapeutic considerations.
@nl
P2093
P356
P1476
Muscle disease in progressive ...... nd therapeutic considerations.
@en
P2093
Campion DS
Clements PJ
P356
10.1002/ART.1780210111
P577
1978-01-01T00:00:00Z